Can, ZehraKara, YakupGüler, Halil İbrahimBirinci, CerenKolaylı, Sevgi2024-10-042024-10-0420232687-6698https://doi.org/10.51435/turkjac.1390923https://search.trdizin.gov.tr/tr/yayin/detay/1222046http://hdl.handle.net/20.500.12403/4548This study investigated that the acetylcholinesterase, urease enzyme inhibition and these enzymes molecular docking as well as antioxidant activity of commercially available amygdalin. While Amygdalin displayed effect anti-urease activity compared to acetohydroxamic acid but, anti-acetylcholine esterase activity a little ineffective compared to donepezil. The molecular docking was performed in order to check binding interactions between the amygdalin and the enzymes. DPPH and FRAP assays were preferred to determine the antioxidant activity. The antioxidant activity (3.39±0.33 µmol Fe2SO47H2O /g, SC50 18.74±0.72 mg/mL using the FRAP and DPPH assays, respectively. Amygdalin's in vitro and in vivo studies are needed for demonstrated that is a therapeutic agent for the treatment of various diseases.eninfo:eu-repo/semantics/openAccessAcetylcholinesteraseUreaseMolecular DockingAntioxidant ActivityAmygdalinArticle5214315010.51435/turkjac.13909231222046